|
Market Closed -
London S.E.
19:35:06 02/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 562.50 GBX | 0.00% |
|
0.00% | -8.54% |
| 08-26 | 4basebio shares jump on new marketing tie-up with US-based Genezen | AN |
| 08-26 | 4basebio, Genezen Partner on Synthetic DNA for Viral Vector Manufacturing | MT |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- 4BB Stock
- Consensus 4basebio PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
